Celldex Therapeutics, Inc. — Director's Dealing 2014

Sep 9, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2014-09-08

Reporting Person: CATLIN AVERY W (Sr. VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-08	Common Stock	M	10000	$4.50	Acquired	24609	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-08	Incentive Stock Options	$4.50	M	10000	Disposed	2020-01-21	Common Stock (10000)	Direct

Footnotes

F1: As of January 21, 2014, the option was fully vested.

F2: Includes 500 shares acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan on July 02, 2014.